Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-067278
Filing Date
2011-03-15
Accepted
2011-03-15 16:50:26
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1333841
2 PLATFORM DEVELOPMENT FUNDING AGREEMENT dex1044.htm EX-10.44 391118
3 GRANT AWARD AGREEMENT dex1045.htm EX-10.45 253611
4 RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 32596
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 4264
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9891
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9876
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4235
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4091
10 GRAPHIC g125884g74l45.jpg GRAPHIC 32600
  Complete submission text file 0001193125-11-067278.txt   2089582
Mailing Address 1420 5TH AVE SUITE 2600 SEATTLE WA 98101
Business Address 1420 5TH AVE SUITE 2600 SEATTLE WA 98101 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34475 | Film No.: 11689090
SIC: 2834 Pharmaceutical Preparations